Based on our findings, we doubt whether paraoxonases (PON) or myeloperoxidase (MPO) are promising candidates to be accepted as reliable biomarkers of depression; both their activity and expression depend on many factors and may not only be related to depression. This evidence concerns the gene PON1 and depressive symptom measurement.